Nobuaki Ikeji

Title: Nobuaki Ikeji: Innovator in Orally Disintegrating Tablet Technology

Introduction

Nobuaki Ikeji is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of orally disintegrating tablets. With a total of 2 patents to his name, Ikeji's work focuses on improving the evaluation methods and devices for these innovative drug delivery systems.

Latest Patents

Ikeji's latest patents include two notable inventions. The first is an "Orally Disintegrating Tablet Evaluating Method," which involves measuring the mass of the tablet, placing it on a preparation placement surface of a test solution supply unit, and measuring the water absorption time for the test solution to penetrate the tablet. This method allows for the calculation of the water absorption rate of the tablet, providing valuable insights into its performance. The second patent is for a "Mouthfeel Evaluation Method and Mouthfeel Evaluation Apparatus for Orally Disintegrating Test Object." This method evaluates the mouthfeel of the orally disintegrating test object by applying predetermined pressure and measuring the loss tangent over time.

Career Highlights

Nobuaki Ikeji is currently employed at Sawai Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceutical technology. His work has been instrumental in advancing the understanding and development of orally disintegrating tablets, which are crucial for improving patient compliance and drug efficacy.

Collaborations

Ikeji has collaborated with notable colleagues, including Masatoshi Nakatani and Masaru Sugita. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical technologies.

Conclusion

Nobuaki Ikeji's contributions to the field of orally disintegrating tablets demonstrate his commitment to innovation in pharmaceutical technology. His patents reflect a deep understanding of the complexities involved in drug delivery systems, paving the way for future advancements in the industry.